Karen Martz

10.3k total citations · 3 hit papers
103 papers, 7.3k citations indexed

About

Karen Martz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Transplantation. According to data from OpenAlex, Karen Martz has authored 103 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 18 papers in Transplantation. Recurrent topics in Karen Martz's work include Renal Transplantation Outcomes and Treatments (18 papers), Prostate Cancer Treatment and Research (12 papers) and Dialysis and Renal Disease Management (11 papers). Karen Martz is often cited by papers focused on Renal Transplantation Outcomes and Treatments (18 papers), Prostate Cancer Treatment and Research (12 papers) and Dialysis and Renal Disease Management (11 papers). Karen Martz collaborates with scholars based in United States, Canada and Ireland. Karen Martz's co-authors include Gerald E. Hanks, Arnold Herskovic, Bahman Emami, Roger W. Byhardt, Jeffrey Brindle, Jay S. Cooper, Muhyi Al‐Sarraf, Lawrence Leichman, Lawrence P. Davis and Vainutis K. Vaitkevicius and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PEDIATRICS.

In The Last Decade

Karen Martz

103 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

1992 1.6k citations Karen Martz et al. profile →
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

1997 525 citations Karen Martz et al. profile →
Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315

1992 467 citations Diana F. Nelson, Karen Martz et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Karen Martz

Since Specialization

Citations

This map shows the geographic impact of Karen Martz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Martz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Martz more than expected).

Fields of papers citing papers by Karen Martz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Martz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Martz. The network helps show where Karen Martz may publish in the future.

Co-authorship network of co-authors of Karen Martz

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Martz. A scholar is included among the top collaborators of Karen Martz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Martz. Karen Martz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of sildenafil in extremely premature infants: a phase I trial 2021 ·Journal of Perinatology ·Wesley Jackson, Daniel González, P. Brian Smith, Namasivayam Ambalavanan, Andrew M. Atz, Gregory M. Sokol, Chi D. Hornik, Dan L. Stewart, (unknown), Brenda B. Poindexter, Shawn K. Ahlfeld, (unknown), Michael Cohen‐Wolkowiez, Karen Martz, Christoph P. Hornik, Matthew M. Laughon	7
2	Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants 2020 ·Clinical Pharmacology & Therapeutics ·Sara Salerno, Andrea N. Edginton, (unknown), Matthew M. Laughon, Namasivayam Ambalavanan, Gregory M. Sokol, Chi D. Hornik, Dan L. Stewart, (unknown), Karen Martz, Daniel González	31
3	Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis 2019 ·Pediatric Transplantation ·(unknown), Karen Martz, Tom Blydt‐Hansen, (unknown)	14
4	Population pharmacokinetics of sildenafil in extremely premature infants 2019 ·British Journal of Clinical Pharmacology ·Daniel González, Matthew M. Laughon, P. Brian Smith, Shufan Ge, Namasivayam Ambalavanan, Andrew M. Atz, Gregory M. Sokol, Chi D. Hornik, Dan L. Stewart, (unknown), Brenda B. Poindexter, Roger Gaedigk, (unknown), Michael Cohen‐Wolkowiez, Karen Martz, Christoph P. Hornik	18
5	Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2019 ·Pediatric Nephrology ·(unknown), (unknown), Elizabeth A. Hunt, Karen Martz, Michaël Somers	1
6	Population Pharmacokinetics and Exploratory Exposure‐Response Relationships of Diazepam in Children Treated for Status Epilepticus 2018 ·CPT Pharmacometrics & Systems Pharmacology ·Lawrence Ku, Christoph P. Hornik, (unknown), James M. Chamberlain, Jeffrey T. Guptill, (unknown), Edmund V. Capparelli, Karen Martz, Ravinder Anand, Michael Cohen‐Wolkowiez, Daniel González	3
7	Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry 2017 ·Pediatric Nephrology ·Donald J. Weaver, Michael J.G. Somers, Karen Martz, Mark Mitsnefes	56
8	Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples From Premature Infants 2013 ·The Pediatric Infectious Disease Journal ·Michael Cohen‐Wolkowiez, (unknown), Barry T. Bloom, Antonio Arrieta, James L. Wynn, Karen Martz, (unknown), Gregory L. Kearns, Edmund V. Capparelli, David S. Siegel, Daniel K. Benjamin, P. Brian Smith	36
9	Health‐related quality of life in pediatric liver transplant recipients compared with other chronic disease groups 2010 ·Pediatric Transplantation ·Christine A. Limbers, Katie Neighbors, Karen Martz, John C. Bucuvalas, Thomas Webb, James W. Varni, Estella M. Alonso, (unknown)	63
10	What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? 2009 ·Pediatric Nephrology ·Richard Ν. Fine, Karen Martz, Donald M. Stablein	69
11	Anemia and Risk of Hospitalization in Pediatric Chronic Kidney Disease 2008 ·Clinical Journal of the American Society of Nephrology ·Amy Staples, Craig S. Wong, Jodi M. Smith, Debbie S. Gipson, Guido Filler, Bradley A. Warady, Karen Martz, Larry A. Greenbaum	43
12	Recombinant growth hormone use pretransplant and risk for post‐transplant lymphoproliferative disease – A report of the NAPRTCS 2008 ·Pediatric Transplantation ·Vikas R. Dharnidharka, Lynya Talley, Karen Martz, Donald M. Stablein, Richard Ν. Fine	19
13	BK Virus Nephropathy in Pediatric Renal Transplant Recipients 2007 ·Clinical Journal of the American Society of Nephrology ·Jodi M. Smith, Vikas R. Dharnidharka, Lynya Talley, Karen Martz, Ruth A. McDonald	83
14	Fast Neutron Radiotherapy for Locally Advanced Prostate Cancer 1993 ·American Journal of Clinical Oncology ·George E. Laramore, John M. Krall, F. Thomas, Kenneth Russell, Moshe Maor, F.R. Hendrickson, Karen Martz, Thomas W. Griffin, L. W. Davis	80
15	Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315 breakdown → 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Diana F. Nelson, Karen Martz, Hugh Bonner, James S. Nelson, Joseph Newall, Herbert D. Kerman, John W. Thomson, Kevin Murray	467
16	A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916) 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Lydia Komarnicky, Theodore L. Phillips, Karen Martz, Sucha O. Asbell, Steven R. Isaacson, Raul C. Urtasun	180
17	Results of the 1989 association of residents in radiation oncology survey 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Benjamin W. Corn, Bernard W. Taylor, Susan J. Knox, Karen Martz, (unknown)	13
18	Practice patterns of palliative care for the united states 1984–1985 1988 ·International Journal of Radiation OncologyBiologyPhysics ·Lawrence R. Coia, Gerald E. Hanks, Karen Martz, Aldo Steinfeld, James J. Diamond, Simon Krämer	61
19	Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate—RTOG experience 1987 ·Urology ·Miljenko V. Pilepich, Richard J. Johnson, Carlos A. Perez, John M. Krall, (unknown), M. Zinninger, William T. Sause, Gerald E. Hanks, Karen Martz	8
20	An analysis of potential physiological predictors of respiratory adequacy following cardiac surgery 1976 ·Journal of Thoracic and Cardiovascular Surgery ·Mark Hilberman, (unknown), Maurice Lamy, H. P. Dietrich, Karen Martz, John J. Osborn	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact